<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02849964</url>
  </required_header>
  <id_info>
    <org_study_id>VIgIE</org_study_id>
    <nct_id>NCT02849964</nct_id>
  </id_info>
  <brief_title>Factors Related to Geographical Variation in the Incidence of End-stage Renal Failure: An Analysis in 5 French Regions</brief_title>
  <acronym>VIgIE</acronym>
  <official_title>Factors Related to Geographical Variation in the Incidence of End-stage Renal Failure: An Analysis in 5 French Regions</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Besancon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Agence de La Biomédecine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Central Hospital, Nancy, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Observatoire Régional de la Santé d'Alsace</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Besancon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The REIN registry highlights significant disparities in the incidence of end-stage renal&#xD;
      disease (ESRD) between regions, especially in the North East of France. According to the&#xD;
      literature, the incidence of ESRD in an area could be related to contextual factors&#xD;
      influencing the needs for dialysis or transplantation (age structure, prevalence of risk&#xD;
      factors, socioeconomic and morbidity levels), as well as to primary and secondary care&#xD;
      provision (general practitioners and nephrologists) and to practice patterns in nephrology.&#xD;
&#xD;
      The aims of this project are the following:&#xD;
&#xD;
        1. to compare the incidence of renal replacement therapy (dialysis or preemptive&#xD;
           transplantation) for ESRD between the &quot;départements&quot; and the &quot;cantons&quot; belonging to the&#xD;
           5 regions of Eastern France (Alsace, Lorraine, Champagne-Ardenne, Bourgogne and&#xD;
           Franche-Comté), while taking into account differences in population sizes and spatial&#xD;
           patterns of the data,&#xD;
&#xD;
        2. to analyse the relations between incidence disparities and socioeconomic environment,&#xD;
           geographic accessibility to primary and secondary care and medical practice patterns,&#xD;
           after adjusting for morbidity and mortality rates (incidence of diabetes, cardiovascular&#xD;
           mortality).&#xD;
&#xD;
      This project will enable a better understanding of the mechanisms involved in the spatial&#xD;
      variations of ESRD incidence, while disentangling effects related to the need from effects&#xD;
      related to service supply in different socio-economic contexts. It will be possible to&#xD;
      identify a lack of equity in access to renal replacement therapy if, after adjusting for need&#xD;
      indicators, there were variations of incidence of ESRD related to availability of service or&#xD;
      to socioeconomic context. Highlighting such effects would lead to search for corrective&#xD;
      measures in collaboration with the different stakeholders.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2015</start_date>
  <completion_date type="Actual">June 2016</completion_date>
  <primary_completion_date type="Actual">June 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Ecologic or Community</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Factors associated with renal replacement therapy</measure>
    <time_frame>Study period: 2010-2014</time_frame>
    <description>Analysis of the association between renal replacement therapy incidence disparities and socioeconomic environment, geographic accessibility to primary and secondary care and medical practice patterns.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">6835</enrollment>
  <condition>Renal Insufficiency</condition>
  <arm_group>
    <arm_group_label>First time renal replacement therapy</arm_group_label>
    <description>Patients beginning renal replacement therapy by renal dialysis or preemptive kidney transplant.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        All person entering renal replacement therapy, either by renal dialysis or preemptive&#xD;
        kidney transplant, between January 1st, 2010 and December 31, 2014, and residing in the&#xD;
        study zone (5 northeastern administrative regions of France), found in the French REIN&#xD;
        registry.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 18 and older&#xD;
&#xD;
          -  Resident of the 5 French administrative regions (Alsace, Bourgogne, Champagne-Ardenne,&#xD;
             Franche-Comté, and Lorraine)&#xD;
&#xD;
          -  First renal replacement therapy by renal dialysis or preemptive kidney transplant&#xD;
             between January 1st, 2010 and December 31, 2014&#xD;
&#xD;
          -  Found in the REIN registry&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Transfer from another French administrative region&#xD;
&#xD;
          -  Return to renal dialysis after graft rejection or a period without dialysis&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Elisabeth Monnet, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre d'Investigation Clinique, CHU Besançon</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Carole Ayav, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre d'Investigation Clinique, CHU Nancy</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centre d'Investigation Clinique, CHU de Besançon</name>
      <address>
        <city>Besançon</city>
        <zip>25030</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital William Morey, Néphrologie</name>
      <address>
        <city>Chalon sur Saône</city>
        <zip>73121</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de Reims, Néphrologie</name>
      <address>
        <city>Reims</city>
        <zip>51100</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre d'Investigation Clinique CHU de Nancy</name>
      <address>
        <city>Vandoeuvre-les-Nancy</city>
        <zip>54500</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2016</verification_date>
  <study_first_submitted>July 27, 2016</study_first_submitted>
  <study_first_submitted_qc>July 28, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 29, 2016</study_first_posted>
  <last_update_submitted>July 28, 2016</last_update_submitted>
  <last_update_submitted_qc>July 28, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 29, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Incidence</keyword>
  <keyword>Renal Replacement Therapy</keyword>
  <keyword>Socioeconomic Factors</keyword>
  <keyword>Clinical Practice Pattern</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Renal Insufficiency</mesh_term>
    <mesh_term>Kidney Failure, Chronic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

